MA24676A1 - Procede pour la synthese d'intermediaires de chloropurine - Google Patents

Procede pour la synthese d'intermediaires de chloropurine

Info

Publication number
MA24676A1
MA24676A1 MA25292A MA25292A MA24676A1 MA 24676 A1 MA24676 A1 MA 24676A1 MA 25292 A MA25292 A MA 25292A MA 25292 A MA25292 A MA 25292A MA 24676 A1 MA24676 A1 MA 24676A1
Authority
MA
Morocco
Prior art keywords
chloropurin
intermediates
synthesis
salts
formula
Prior art date
Application number
MA25292A
Other languages
English (en)
Inventor
Martin Francis Jones
Christopher John Wallis
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA24676A1 publication Critical patent/MA24676A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA PRÉSENTE INVENTION PORTE SUR UN PROCÉDÉ POUR LA PRÉPARATION D'UN ANALOGUE CARBOCYCLIQUE DE NUCLÉOSIDE PURINE DE LA FORMULE (I), SES SELS ET LES DÉRIVÉS PHARMACEUTIQUEMENT ACCEPTABLES DE CEUX-CI.
MA25292A 1997-10-14 1998-10-13 Procede pour la synthese d'intermediaires de chloropurine MA24676A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721780.6A GB9721780D0 (en) 1997-10-14 1997-10-14 Process for the synthesis of chloropurine intermediates

Publications (1)

Publication Number Publication Date
MA24676A1 true MA24676A1 (fr) 1999-07-01

Family

ID=10820547

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25292A MA24676A1 (fr) 1997-10-14 1998-10-13 Procede pour la synthese d'intermediaires de chloropurine

Country Status (43)

Country Link
US (1) US6646125B1 (fr)
EP (1) EP1023292B1 (fr)
JP (1) JP4531250B2 (fr)
KR (1) KR100543845B1 (fr)
CN (1) CN1160354C (fr)
AP (1) AP1182A (fr)
AR (1) AR014921A1 (fr)
AT (1) ATE249461T1 (fr)
AU (1) AU738462B2 (fr)
BG (1) BG64597B1 (fr)
BR (1) BR9813048B1 (fr)
CA (1) CA2306958C (fr)
CO (1) CO4980899A1 (fr)
CZ (1) CZ294482B6 (fr)
DE (1) DE69818084T2 (fr)
DK (1) DK1023292T3 (fr)
EA (1) EA003183B1 (fr)
EE (1) EE04059B1 (fr)
EG (1) EG21730A (fr)
ES (1) ES2205553T3 (fr)
GB (1) GB9721780D0 (fr)
GE (1) GEP20022679B (fr)
HR (1) HRP20000216B1 (fr)
HU (1) HUP0003984A3 (fr)
ID (1) ID24927A (fr)
IL (1) IL135323A (fr)
IN (1) IN184590B (fr)
IS (1) IS2195B (fr)
MA (1) MA24676A1 (fr)
MY (1) MY127470A (fr)
NO (1) NO325030B1 (fr)
NZ (1) NZ503679A (fr)
OA (1) OA11370A (fr)
PE (1) PE121899A1 (fr)
PL (1) PL188477B1 (fr)
PT (1) PT1023292E (fr)
RS (1) RS49710B (fr)
SK (1) SK285331B6 (fr)
TR (1) TR200000976T2 (fr)
TW (1) TW436488B (fr)
UA (1) UA54550C2 (fr)
WO (1) WO1999019327A1 (fr)
ZA (1) ZA989338B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ298144B6 (cs) 1997-11-27 2007-07-04 Lonza Ag Zpusob výroby (1S,4R)- nebo (1R,4S)-4-(2-amino-6-chlor-9-H-purin-9-yl)-2-cyklopenten-1-methanolu
FR2849030A1 (fr) * 2002-12-20 2004-06-25 Isochem Sa Procede de preparation des n-(2-amino-4, 6-dihalogenopyrimidin-5-yl) formamides
GB0320738D0 (en) 2003-09-04 2003-10-08 Glaxo Group Ltd Novel process
CN100465174C (zh) * 2006-06-13 2009-03-04 中国科学院上海有机化学研究所 制备光学纯阿巴卡韦的方法
KR101109476B1 (ko) * 2009-06-26 2012-01-31 현대제철 주식회사 실린더 교체용 지그장치
LT3494972T (lt) 2010-01-27 2024-03-12 Viiv Healthcare Company Dolutegraviro ir lamivudino kompozicija živ infekcijai gydyti
CN104672239A (zh) * 2013-11-26 2015-06-03 上海迪赛诺化学制药有限公司 一种采用一锅法制备阿巴卡韦式v中间体的工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268672A (en) * 1977-02-09 1981-05-19 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
JPS6175A (ja) * 1984-03-06 1986-01-06 ブリストル−マイア−ズ　コムパニ− 神経弛緩剤、１‐フルオロフェニルブチル‐４‐（５‐ハロ‐２‐ピリミジニル）ピペラジン誘導体
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
PT89482B (pt) * 1988-01-20 1994-02-28 Univ Minnesota Processo para a preparacao de derivados de nucleosidos disesoxi-didesidro-carboxilico
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5126452A (en) * 1990-04-06 1992-06-30 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
US5329008A (en) 1993-04-07 1994-07-12 Glaxo Inc. Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone
GB9402161D0 (en) * 1994-02-04 1994-03-30 Wellcome Found Chloropyrimidine intermediates
SK285228B6 (sk) * 1997-05-13 2006-09-07 Lonza Ag Spôsob výroby racemického alebo opticky aktívnehoderivátu 4-(hydroxymetyl)-2-cyklopenténu a racemicky N-butyryl-1-amino-4- (hydroxymetyl)-2-cyklopentén

Also Published As

Publication number Publication date
OA11370A (en) 2004-01-27
GEP20022679B (en) 2002-04-25
EA200000318A1 (ru) 2000-12-25
SK285331B6 (sk) 2006-11-03
BG104352A (en) 2001-02-28
PL339904A1 (en) 2001-01-15
CN1281457A (zh) 2001-01-24
CN1160354C (zh) 2004-08-04
IL135323A (en) 2004-07-25
KR20010015744A (ko) 2001-02-26
ATE249461T1 (de) 2003-09-15
IL135323A0 (en) 2001-05-20
HRP20000216B1 (en) 2002-08-31
NO20001896L (no) 2000-06-13
PL188477B1 (pl) 2005-02-28
NO325030B1 (no) 2008-01-21
WO1999019327A1 (fr) 1999-04-22
HUP0003984A2 (hu) 2001-04-28
YU20200A (sh) 2003-02-28
DK1023292T3 (da) 2003-11-10
AU738462B2 (en) 2001-09-20
EE04059B1 (et) 2003-06-16
TR200000976T2 (tr) 2000-11-21
JP2001519432A (ja) 2001-10-23
EG21730A (en) 2002-02-27
AR014921A1 (es) 2001-04-11
CO4980899A1 (es) 2000-11-27
AP1182A (en) 2003-06-18
ID24927A (id) 2000-08-31
CA2306958A1 (fr) 1999-04-22
HK1027807A1 (en) 2001-01-23
HRP20000216A2 (en) 2000-08-31
GB9721780D0 (en) 1997-12-10
IS5423A (is) 2000-03-28
BG64597B1 (bg) 2005-08-31
HUP0003984A3 (en) 2002-12-28
US6646125B1 (en) 2003-11-11
TW436488B (en) 2001-05-28
NO20001896D0 (no) 2000-04-12
SK5362000A3 (en) 2001-03-12
MY127470A (en) 2006-12-29
CA2306958C (fr) 2007-09-04
PE121899A1 (es) 1999-12-20
IS2195B (is) 2007-01-15
DE69818084T2 (de) 2004-07-15
DE69818084D1 (de) 2003-10-16
EP1023292A1 (fr) 2000-08-02
JP4531250B2 (ja) 2010-08-25
BR9813048A (pt) 2000-08-15
ZA989338B (en) 2000-04-13
BR9813048B1 (pt) 2010-07-13
RS49710B (sr) 2007-12-31
AU9547698A (en) 1999-05-03
AP2000001790A0 (en) 2000-06-30
KR100543845B1 (ko) 2006-01-23
CZ20001367A3 (cs) 2000-10-11
IN184590B (fr) 2000-09-09
ES2205553T3 (es) 2004-05-01
EP1023292B1 (fr) 2003-09-10
UA54550C2 (uk) 2003-03-17
NZ503679A (en) 2002-09-27
EE200000162A (et) 2001-04-16
EA003183B1 (ru) 2003-02-27
PT1023292E (pt) 2004-02-27
CZ294482B6 (cs) 2005-01-12

Similar Documents

Publication Publication Date Title
TW262474B (fr)
EA199700124A1 (ru) Производные гуанина
FR2596761B1 (fr) Derives de nucleosides et leur utilisation pour la synthese d'oligonucleotides
BG100916A (en) Process for the diastereoselective synthesis of nucleoside analogues
CO5180579A1 (es) Composicion oral solida que comprende levidopa, carbidopa y entacapone
MA24676A1 (fr) Procede pour la synthese d'intermediaires de chloropurine
NO20084343L (no) Fremgangsmate for fremstilling av 6-(4-fenylbutoksy)heksylaminderivater
TNSN99060A1 (fr) Procede pour la synthese d'intermediaires chloropurine
ES556551A0 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina
CA2261591A1 (fr) Inhibiteurs de l'adenosine desaminase
JPS6434978A (en) Benzimidazole derivative, manufacture and application to medicine
EP0413544A3 (en) Purine derivatives, process for their preparation, pharmaceutical compositions and intermediates
BR9709791A (pt) Intermediários para a síntese de oligonucleotíedeos
PT98186A (pt) Processo para a preparacao de purinil- e de pirimidinil-tetra-hidrofuranos e de composicoes farmaceuticas que os contem
ES2009236A6 (es) Procedimiento para la preparacion de derivados de piperazina.
BE1003113A5 (fr) Procede de preparation de derives de nucleosides.
ECSP982692A (es) Proceso para la sintesis de los compuestos intermediarios de la cloropurina
FR2653781B1 (fr) Procede de synthese de derives d'adenosine phosphate et derives obtenus.
PA8470601A1 (es) Proceso para la sintesis de los compuestos intermediarios de cloropurina
KR860001866B1 (en) Process for preparing 2'-deoxy-5-substituted uridine derivatives
LU88449I2 (fr) Fleroxacine et ses dérivés pharmaceutiquement acceptables.